Apollomics Inc.
corporate_fare Company Profile
Apollomics Inc. (NASDAQ:APLM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for APLM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for APLM spans 6-K, 4, SCHEDULE 13D/A, 20-F.
Recent high-impact activity:
- Apollomics Posts $8.8M H1 Loss With Just $1.0M Cash on Hand
- Apollomics H1 2026: Going-Concern Warning With Only $1.0M Cash
- CFO Invests $400K in Private Placement, Boosting Insider Confidence
- CEO Chen Acquires 536,667 Shares in $5.55M PIPE, Boosting Stake to 49.76%
- $10M Private Placement Priced at $15/Share, Insiders Participate
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 5,402 shares in APLM as of the October 30, 2026 settlement, a 0.1% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 3.2% of APLM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
APLM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.